We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ENTBF market cap is 773.95k. The company's latest EPS is CAD -0.0508 and P/E is -2.56.
Year End November 29 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 22k | 214k | 250k |
Operating Income | -101k | -905k | -7.44M | -2.82M | 131k |
Net Income | -146k | -4.38M | -8.89M | -8.52M | -300k |
Year End November 29 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 1.72M | 4.47M | 9.98M | 769k | 401k |
Total Liabilities | 28k | 728k | 928k | 154k | 85k |
Total Equity | 1.69M | 3.75M | 9.05M | 615k | 316k |
Year End November 29 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -102k | -2.84M | -5.62M | -1.95M | -359k |
Investing | -85k | 1.08M | -99k | 585k | 24k |
Financing | 95k | 4.43M | 4.98M | N/A | N/A |
Market Cap | 773.95k |
Price to Earnings Ratio | -2.56 |
Price to Sales Ratio | 3.07 |
Price to Cash Ratio | 2.23 |
Price to Book Ratio | 2.43 |
Dividend Yield | - |
Shares Outstanding | 5.91M |
Average Volume (1 week) | 1.71k |
Average Volume (1 Month) | 1.23k |
52 Week Change | -21.08% |
52 Week High | 0.29 |
52 Week Low | 0.043 |
Spread (Intraday) | 0.05 (32.73%) |
Company Name | Entheon Biomedical Corporation (QB) |
Address |
10th floor, 595 howe street vancouver, british columbia V6C 2T5 |
Website | https://www.entheonbiomedical.com |
Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions